We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ZLDPF market cap is 5.07B. The company's latest EPS is DKK -21.0364 and P/E is -4.70.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 390.31M | 293.33M | 191.6M | 358.77M | 62.69M |
| Operating Income | -792.36M | -1.05B | -1.06B | -572.24M | -1.27B |
| Net Income | -846.73M | -1.02B | -1.2B | -703.74M | -1.08B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 1.76B | 2.07B | 1.54B | 1.98B | 9.51B |
| Total Liabilities | 532.64M | 1.14B | 723.9M | 387.15M | 888.86M |
| Total Equity | 1.23B | 927.8M | 815.91M | 1.59B | 8.62B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | -688.72M | -1.21B | -942.21M | -425.67M | -930.82M |
| Investing | -196.81M | -18.12M | 281.26M | -1.09B | -7.33B |
| Financing | 760.94M | 1.33B | 587.4M | 907.01M | 8.29B |
| Market Cap | 5.07B |
| Price to Earnings Ratio | -4.70 |
| Price to Sales Ratio | 80.91 |
| Price to Cash Ratio | 10.56 |
| Price to Book Ratio | 0.59 |
| Dividend Yield | - |
| Shares Outstanding | 51.28M |
| Average Volume (1 week) | 2.52k |
| Average Volume (1 Month) | 1.3k |
| 52 Week Change | -3.92% |
| 52 Week High | 141.742 |
| 52 Week Low | 71.20 |
| Spread (Intraday) | 3.15 (3.51%) |
| Company Name | Zealand Pharma AS (PK) |
| Address |
sydmarken 11 soborg DK-2600 |
| Website | https://www.zealandpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
